Advertisement
Screener

Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense

Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense

Satsuma Pharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $1.09 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-05-11

  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $1.09M, a 11.78% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $1.52M, a 28.37% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $1.59M, a 24.59% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $1.35M, a 5.51% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2022 was $5.71M, a 6.36% increase from fiscal 2021.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2021 was $5.36M, a 33.50% increase from fiscal 2020.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2020 was $4.02M, a 437.88% increase from fiscal 2019.
  • Satsuma Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2019 was $747.00K, a 339.41% increase from fiscal 2018.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2023-03-31$1.09M
10-Q · filed 2023-05-11
$2.62M
derived: sum of 2 quarters · filed 2023-05-11
$4.20M
derived: sum of 3 quarters · filed 2023-05-11
$5.56M
derived: sum of 4 quarters · filed 2023-05-11
2022-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$3.11M
derived: sum of 2 quarters · filed 2023-03-28
$4.47M
derived: sum of 3 quarters · filed 2023-03-28
$5.71M
10-K · filed 2023-03-28
2022-09-30$1.59M
10-Q · filed 2022-11-03
$2.94M
derived: sum of 2 quarters · filed 2022-11-03
$4.18M
10-Q · filed 2022-11-03
$5.37M
derived: sum of 4 quarters · filed 2023-05-11
2022-06-30$1.35M
10-Q · filed 2022-08-09
$2.59M
10-Q · filed 2022-08-09
$3.78M
derived: sum of 3 quarters · filed 2023-05-11
$5.05M
derived: sum of 4 quarters · filed 2023-05-11
2022-03-31$1.24M
10-Q · filed 2023-05-11
$2.43M
derived: sum of 2 quarters · filed 2023-05-11
$3.70M
derived: sum of 3 quarters · filed 2023-05-11
$5.13M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$2.46M
derived: sum of 2 quarters · filed 2023-03-28
$3.90M
derived: sum of 3 quarters · filed 2023-03-28
$5.36M
10-K · filed 2023-03-28
2021-09-30$1.27M
10-Q · filed 2022-11-03
$2.71M
derived: sum of 2 quarters · filed 2022-11-03
$4.18M
10-Q · filed 2022-11-03
$5.61M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$1.43M
10-Q · filed 2022-08-09
$2.90M
10-Q · filed 2022-08-09
$4.33M
derived: sum of 3 quarters · filed 2022-08-09
$5.55M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.47M
10-Q · filed 2022-05-10
$2.90M
derived: sum of 2 quarters · filed 2022-05-10
$4.11M
derived: sum of 3 quarters · filed 2022-05-10
$5.04M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$2.65M
derived: sum of 2 quarters · filed 2022-03-15
$3.57M
derived: sum of 3 quarters · filed 2022-03-15
$4.02M
10-K · filed 2022-03-15
2020-09-30$1.22M
10-Q · filed 2021-11-09
$2.14M
derived: sum of 2 quarters · filed 2021-11-09
$2.59M
10-Q · filed 2021-11-09
$2.91M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$924.00K
10-Q · filed 2021-08-10
$1.37M
10-Q · filed 2021-08-10
$1.70M
derived: sum of 3 quarters · filed 2021-08-10
$1.92M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$449.00K
10-Q · filed 2021-05-11
$774.00K
derived: sum of 2 quarters · filed 2021-05-11
$998.00K
derived: sum of 3 quarters · filed 2021-05-11
$1.14M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$325.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
$549.00K
derived: sum of 2 quarters · filed 2021-03-25
$693.00K
derived: sum of 3 quarters · filed 2021-03-25
$747.00K
10-K · filed 2021-03-25
2019-09-30$224.00K
10-Q · filed 2020-11-10
$368.00K
derived: sum of 2 quarters · filed 2020-11-10
$422.00K
10-Q · filed 2020-11-10
$454.00K
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$144.00K
10-Q · filed 2020-08-11
$198.00K
10-Q · filed 2020-08-11
$230.00K
derived: sum of 3 quarters · filed 2020-08-11
$261.00K
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31$54.00K
10-Q · filed 2020-05-12
$86.00K
derived: sum of 2 quarters · filed 2020-05-12
$117.00K
derived: sum of 3 quarters · filed 2020-05-12
2018-12-31$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$63.00K
derived: sum of 2 quarters · filed 2020-03-10
$170.00K
10-K · filed 2020-03-10
2018-09-30$31.00K
10-Q · filed 2019-11-12
$138.00K
10-Q · filed 2019-11-12
2017-12-31$66.00K
10-K · filed 2020-03-10